Astellas begins construction of R&D and manufacturing facilities in Japan and US

Astellas Pharma Inc. announced the start of construction of new research, development and manufacturing facilities for drugs using innovative modalities including antibodies and cell therapies in Toyama and Tsukuba, Japan, and Massachusetts, United States.

“Astellas is focused on creating innovative healthcare solutions for patients with high unmet medical needs through unique combinations of Biology and Modality/Technology based on emerging science.”stage.mediaroom.com

• 1 source
• stage.mediaroom.comGlobal News | AstellasOct 31, 2018

Summarized from public sources; check the original articles before acting on it.